Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07019675 |
| Consolidated Lead Sponsor | Sichuan Kelun-Biotech Biopharmaceutical Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 192 participants (ESTIMATED) |
| Registered Start Date | 2025-08-29 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The first affiliated hospital of Zhengzhou University | Zhengzhou, China | Open Hospital Dossier -> |
| Hubei Cancer Hospital | Wuhan, China | Open Hospital Dossier -> |
| Renmin Hospital of Wuhan University | Wuhan, China | Open Hospital Dossier -> |
| Xiangyang Central Hospital | Xiangyang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.